Navigation Links
Sea lice treatment increased in Norwegian fish breeding in 2009
Date:3/16/2010

Last year, increased resistance to sea lice treatments such as the pyrethroids cypermethrin and deltamethrin, as well as emamectine, was observed. Pyrethroid use still increased from 2008 to 2009, although use of emamectine reduced significantly. Older sea lice treatments are being used again due to resistance problems, e.g. azametiphos, diflubenzuron and teflubenzuron. Hydrogen peroxide, which has not been used since 1997, was also used again in 2009, mainly under controlled conditions in wellboats.

The increase in antibacterial sales from 2008-2009 was marginal and, when seen in relation to the biomass of bred fish, the usage is very low. Prescription-based statistics from the Norwegian Food Safety Authority for 2000-2008 show that antibacterials have been increasingly used in the treatment of newer breeding fish species, especially cod. For this period, the increase in the use in cod was positively correlated to the increase in biomass of cod produced. Data for sales per fish species for 2009 are not yet available.

Anthelmintics have shown an annual reduction in sales since 2004 and fungicides are back to 2008 levels.

The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders.


'/>"/>

Contact: Irene Litleskare
Irene.Litleskare@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Nicotinic receptors may be important targets for treatment of multiple addictions
2. A new radiation therapy treatment developed for head and neck cancer patients
3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
4. Presence of gene mutation helps guide thyroid cancer treatment
5. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
6. New genetic research into nicotine addiction shows promise for personalized treatment
7. Interleukin-8, key marker for colorectal cancer treatment
8. New class of drug offers hope to treatment-resistant AIDS patients
9. Paradigm shift in Alzheimerss research: new treatments
10. New research on structure of bones raises questions for treatment of osteoporosis
11. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced ... presenting at the Annual Biocom Global Life Science Partnering ... at 11:15 AM, at the Torrey Pines Lodge, in ... the organizers at Biocom who have chosen our company, ... of biotechnology companies, investors, and clinical researchers," said Mr. ...
(Date:2/22/2017)... ... 22, 2017 , ... LabRoots , the leading provider of educational and ... pleased to announce the launch of a new scholarship for young scientists seeking a ... merit-based scholarship is open to all high school seniors, 17 years or older; as ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech consulting firm ... director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 ... more than a decade with leading market research firm, GfK. He began his ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, CloudMine, ... applications, announced a partnership with Redox, a leader in cloud-based healthcare integration and ... systems while keeping data secure in the cloud. , The digital health developers, ...
Breaking Biology Technology: